TickerFactsScreenerDevelopers

ARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$64.43M2017: -$23.94M2018: -$47.22M2019: $173.03M2020: -$95.80M2021: $171.31M2022: -$136.13M2023: -$153.89M2024: -$462.85M2025: $179.55M$179.55M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$179.55M+138.8%
2024-$462.85M-200.8%
2023-$153.89M-13.0%
2022-$136.13M-179.5%
2021$171.31M+278.8%
2020-$95.80M-155.4%
2019$173.03M+466.4%
2018-$47.22M-97.3%
2017-$23.94M+62.8%
2016-$64.43M—